

1668. Rev Med Interne. 2015 Aug;36(8):540-7. doi: 10.1016/j.revmed.2015.01.003. Epub
2015 Feb 7.

[HPV (Human Papilloma Virus) implication in other cancers than gynaecological].

[Article in French]

Badoual C(1), Tartour E(2), Roussel H(3), Bats AS(4), Pavie J(5), Pernot S(6),
Weiss L(5), Mohamed AS(7), Thariat J(8), Hoffmann C(9), Péré H(10).

Author information: 
(1)Service d'anatomie pathologique, faculté Paris-Descartes, hôpital européen
Georges-Pompidou, AP-HP, 20-40, rue Leblanc, 75015 Paris, France; Inserm U 970,
équipe 10, PARCC, 75015 Paris, France. Electronic address:
cecile.badoual@egp.aphp.fr.
(2)Inserm U 970, équipe 10, PARCC, 75015 Paris, France; Laboratoire d'immunologie
clinique, faculté Paris-Descartes, hôpital européen Georges-Pompidou, AP-HP,
20-40, rue Leblanc, 75015 Paris, France.
(3)Service d'anatomie pathologique, faculté Paris-Descartes, hôpital européen
Georges-Pompidou, AP-HP, 20-40, rue Leblanc, 75015 Paris, France; Inserm U 970,
équipe 10, PARCC, 75015 Paris, France.
(4)Service de gynécologie, faculté Paris-Descartes, hôpital européen
Georges-Pompidou, AP-HP, 20-40, rue Leblanc, 75015 Paris, France.
(5)Service d'immunologie clinique, faculté Paris-Descartes, hôpital européen
Georges-Pompidou, AP-HP, 20-40, rue Leblanc, 75015 Paris, France.
(6)Service de hépato-gastro-entérologie et oncologie digestive, faculté
Paris-Descartes, hôpital européen Georges-Pompidou, AP-HP, 20-40, rue Leblanc,
75015 Paris, France.
(7)Laboratoire de virologie, faculté Paris-Descartes, hôpital européen
Georges-Pompidou, AP-HP, 20-40, rue Leblanc, 75015 Paris, France.
(8)Service de radiothérapie, centre Antoine Lacassagne, 227, avenue de la
Lanterne, 06200 Nice, France.
(9)Service d'ORL, hôpital européen Georges-Pompidou, 20-40, rue Leblanc, 75015
Paris, France.
(10)Laboratoire de virologie, faculté Paris-Descartes, hôpital européen
Georges-Pompidou, AP-HP, 20-40, rue Leblanc, 75015 Paris, France; Inserm U 970,
équipe 10, PARCC, 75015 Paris, France.

Worldwide, approximately 5 to 10% of the population is infected by a Human
Papilloma Virus (HPV). Some of these viruses, with a high oncogenic risk (HPV
HR), are responsible for about 5% of cancer. It is now accepted that almost all
carcinomas of the cervix and the vulva are due to an HPV HR (HPV16 and 18)
infection. However, these viruses are known to be involved in the carcinogenesis 
of many other cancers (head and neck [SCCHN], penis, anus). For head and neck
cancer, HPV infection is considered as a good prognostic factor. The role of HPV 
HR in anal cancer is also extensively studied in high-risk patient's population. 
The role of HPV infection in the carcinogenesis of esophageal, bladder, lung,
breast or skin cancers is still debated. Given the multiple possible locations of
HPV HR infection, the question of optimizing the management of patients with a
HPV+ cancer arises in the implementation of a comprehensive clinical and
biological monitoring. It is the same in therapeutics with the existence of a
preventive vaccination, for example.

Copyright © 2015 Société nationale française de médecine interne (SNFMI).
Published by Elsevier SAS. All rights reserved.

DOI: 10.1016/j.revmed.2015.01.003 
PMID: 25661671  [Indexed for MEDLINE]
